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Exercises are often recommended for patients suffering from anemia to improve physical con-
ditioning and hematologic parameters. Hence, the present study aimed to investigate the impact
of moderate intensity aerobic exercise on chemotherapy-induced anemia. Thirty elderly women
with breast cancer underwent chemotherapy and were randomly assigned into two equal
groups; Group A received aerobic exercise for 25–40 min at 50–70% of the maximum heart rate,
3 times/week for 12 weeks in addition to usual daily living activities, medication and nutritional
support. Group B who did not train served as controls. Hemoglobin (Hb), and red blood cell
count (RBCs) were evaluated pre-treatment and after 12 weeks of training. There were signifi-
cant declines of both Hb (t= 16.30; P< 0.001) and RBCs (t= 10.38; P< 0.001) in group B
relative to group A. Regarding group A, Hb increased from 11.52 ± 0.62 to 12.10 ± 0.59 g/dL
with a 5.03% change, while RBCs increased from 4.24 ± 0.37 to 4.49 ± 0.42 million cells/lL
with a 5.89% change. Between-group differences were noteworthy regarding Hb (t= 5.34;
P< 0.001) and RBCs (t= 5.314; P< 0.001). The results indicate that regular participation
in moderate intensity aerobic exercise can enhance chemotherapy-induced anemia.
 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Chemotherapy-induced anemia (CIA) is a common complica-
tion in patients receiving myelosuppressive chemotherapy [1].
Blood hemoglobin (Hb) level of less than 12 g/dL is frequently
defined as anemia, but many individuals may not feel much
difference until the hemoglobin level falls below 11 g/dL [2].
Anemia is associated with fatigue and dyspnea on exertion,
which can affect a patient’s capacity to perform normal daily
living activities [1,3].
Current treatment choices for CIA incorporate red blood
cell (RBC) transfusions and erythropoiesis-stimulating agents
(ESAs); however, both treatments are associated with an
increased risk of thrombotic events [4]. Also, ESAs might be
connected with conceivable diminished survival and shortened
time to tumor progression in patients with cancer, and RBC
transfusions carry a risk of infection, transfusion-related reac-
tions, and possible decreased survival [4–6]. Given these safety
concerns, other treatment alternatives for CIA that are effica-
cious and safe are required.
The overall goal of treatment in individuals with CIA is
reduction in transfusion requirements and maximization of
quality of life [7]. Exercise could be an appropriate non-
pharmacologic intervention to counteract the decline in ery-
throcyte observed in many breast cancer patients undergoing
chemotherapy. Aerobic exercise training (AET) is associated
with improved hemorheology [8,9] and can increase blood vol-
ume through an increase in plasma volume and RBC mass [10].
Few studies have evaluated the effect of exercise training on ery-
throcyte in breast cancer patients undergoing adjuvant
chemotherapy. Previous studies have reported positive changes
in erythrocyte with exercise in cancer patients, but the samples
were clinically heterogeneous, with inefficient training intensity
or brief interventions of 6–7 weeks, which occurred after
chemotherapy [11,12]. So the purpose of this study was to exam-
ine whether moderate-intensity aerobic exercise would have an
effect on erythrocyte in elderly women with breast cancer com-
pared with non-training ones also undergoing chemotherapy.Patients and method
Thirty women patients with breast cancer (aged 60–70 years),
who underwent chemotherapy, were screened and randomly
assigned to either Control or Intervention group to participate
in this 12-week randomized-controlled trial. They were
recruited from National Cancer Institute, Cairo University,
to participate in this study.
Patients were selected to be enrolled into this study after
they had fulfilled the inclusion criteria of the study; female
patients with breast cancer undergoing chemotherapy, they
were medically stable and not receiving Erythropoietin therapy,
their BMI ranged from 30 to 35, and they had an inactive life-
style for at least the previous 6 months. Patients had provided
informed consent for participation in the study and for publica-
tion of the results. This study was approved by University Ethics
Committee for scientific research [No: P.T.REC/012/001353].
Exclusion criteria were BMI more than 35, age older than
70 or younger than 60 years. Patients who received Erythro-
poietin treatments, suffered uncorrected visual problems, had
scars under their feet, and had a history of serious cerebrovas-
cular or cardiovascular diseases, or severe musculoskeletal
problems restricting physical activity.
Initial medical screening was performed for every patient by
an oncologist and clinical history was recorded for all
participants.
Study protocol and the objectives of the study were alto-
gether explained to all participants, who were asked to main-
tain their pharmacologic treatment, general eating routine,
and typical daily activities and lifestyle all through the study.
Design of the study
Patients who fulfilled the inclusion criteria of the study were
randomly assigned to either group A, the study group, who
received aerobic exercise for 25–40 min at 50–70% of the max-
imum heart rate, 3 times/week for 12 weeks in addition to
usual daily living activities, medication and nutritional sup-
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daily living activities in addition to administration of their
medication and nutritional support.
Randomization was done by opening an opaque envelope
prepared by an independent individual using random number
generation.
Instrumentation
For evaluation
Coulter hematology analyzer. Beckman-Coulter AcT 5 Diff CP
Hematology Analyzer (Coulter electronics, Atlanta, USA-
6605580) was used to measure Hb % and RBCs for all patients
in both groups before and after treatment [13].
Weight and height scale. ZT-120 (Wincom Company Ltd.,
Hunan, China) was used to measure the weight and height of
each participant and then calculate the BMI [weight (kg)/height
(m2)].
For training
Electronic treadmill. Electronic treadmill Manufactured by
Bonte BV - JK Hedel – Holland, 02-328 was used for exercise
training. The apparatus is equipped with a display screen
showing time in minutes and speed in kilometers per hour.
Outcome measures
Both groups underwent an identical battery of tests: baseline
(before training) and after 12-week exercise training program
(after training). The evaluated parameters included Hb and
RBCs measurement.
Firstly, data on the subjects’ characteristics were collected
in the first session including resting heart rate (HR) (beats/
min) and resting respiratory rate (cycles/min). In addition,
HR and blood pressure were measured during the sessions to
exclude any signs or symptoms that may interfere with the pro-
gression of the study. Weight (kg) was measured to the closest
0.1 kg using a standard weight scale.
Height was measured to the closest 0.1 cm with the subject
standing in an erect position against a vertical scale of a por-
table stadiometer. BMI (kg/m2) was estimated as weight in
kilograms divided by squared height in meters to exclude
BMI more than or equal to 35.
Laboratory investigations
Complete blood count measurements
Five milliliters of blood were drained under an aseptic condi-
tion from the ante-cubital fossa on the side of the untreated
breast by guaranteed technicians with the subject in a seated
position. Blood draws were performed principally in the
morning and approximately 90 min before the treadmill
exercise evaluations, with participants in a postprandial state.
Normal values used for women were 12.1–15.1 g/dL for Hb,
and 4.2–5.4 million cells/lL for RBCs.
Training procedures
After warm-ups, participants of this group performed walking
on a treadmill three times per week (on nonconsecutive days).Aerobic exercise intensity was determined using the Karvonen
formula in which Target Heart Rate = [(max HR  resting
HR) % intensity] + resting HR, where maximum heart
rate = 220-age [14].
Parameters of exercise program
Mode: Walking on a treadmill
Duration: 25–40 min
Intensity: 50–70% of maximum heart rate (MHR).
(Karvonen formula)
Frequency: 3 times per week [15]
Treatment duration: 12 weeks
Each exercise session consisted of
Warming up: Light walking for 5 min
Active phase: Walking on a treadmill at moderate speed
with no inclination for 15–30 min
Cooling down: Light walking for 5 min [16]
Progression of exercise program
Duration: Increased by 5 min every 2 weeks until 40 min
were attained and then maintained
Intensity: By the 4th week, patient was exercised
at 70% of measured maximum heart rate [16]After the end of the session, patients were asked to step off the
treadmill and were observed carefully for any signs of fatigue
i.e. fainting or loss of consciousness (syncope), near-syncope,
rapid heartbeat (palpitation), or dizziness.Data collection
For each group, both demographic and clinical characteristics
[hemoglobin (Hb), and red blood cell count (RBCs)] of
patients were collected pre and post training.
Statistical analysis
Descriptive statistics for all parameters in the form of
Mean and standard deviation of [Demographic and clinical
characteristics; Hb and RBCs] and percentage of change in
Hb and RBCs post training were evaluated.
Inferential statistics in the form of
Paired t-test to examine the changes in Hb and RBCs pre and
post training in each group and Independent t-test to
compare between the two groups regarding the Hb and RBCs
pre and post training. The level of significance was set at
P 6 0.05 [17].Results
Demographic and clinical characteristics of patients in both
groups
In the baseline (pre-training) evaluation, results revealed that
there were non-significant differences between the two groups
with regard to demographic characteristics and clinical
parameters where (P> 0.05), are shown in Table 1.
Table 1 Demographic and clinical characteristics of patients in both groups (Mean ± SD).
Variables Group A (N= 15) Group B (N= 15) t-value P-value
Age (year) 54.6 ± 4.23 58.25 ± 2.65 0.61 0.540
Height (m) 162.07 ± 4.89 162.33 ± 5.70 0.137 0.892
Weight (kg) 91.27 ± 9.40 93.33 ± 14.21 0.470 0.642
Body Mass Index (kg/m2) 34.81 ± 3.44 35.25 ± 3.36 0.354 0.726
Hb (g/dL) 11.52 ± 0.62 11.70 ± 0.96 0.60 0.548
RBCs (106/lL) 4.24 ± 0.37 4.30 ± 0.317 0.43 0.668
SD= Standard Deviation. Level of significance at P 6 0.05.
Table 2 Hemoglobin (Hb) in the two groups pre and post-treatment.
Variable Groups
Hb (g/dL)
Group (A) (N= 15) Group (B) (N= 15)
Pre-treatment Post-treatment Pre-treatment Post-treatment
Mean ± SD 11.52 ± 0.62 12.10 ± 0.59 11.70 ± .96 10.32 ± 1.04
Percentage of Change 5.03% 11.79%
t-value 8.52 16.30
P-value 0.001* 0.001*
SD= Standard Deviation. Level of significance at P 6 0.05.
* P 6 0.05.
Error bars denotes standard deviation.
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Fig. 1 Hemoglobin (Hb) in the two groups pre and post-
treatment.
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Hemoglobin in the two groups pre and post-treatment
Table 2 shows the statistical analysis of the mean difference of
Hb pre-treatment and 12-week after treatment (post-
treatment) with significant differences found in Hb measures
between Group A and Group B following training. Group A
experienced significant increases (t= 8.52; P< 0.001) in
Hb from 11.52 ± 0.62 g/dL to 12.10 ± 0.59 g/dL, with a
5.03% change. However Group B experienced significant
declines (t= 16.30; P< 0.001) in Hb from 11.70 ± .96 g/dL
to 10.32 ± 1.04 g/dL with a 11.79% change. Results are
illustrated in Fig. 1.
Red blood cell count in the two groups pre and post-treatment
Table 3 shows the statistical analysis of the mean difference of
RBCs count pre-treatment and 12-week after treatment (post-
treatment) with significant differences found in RBCs mea-
sures between Group A and Group B following training.
Group A experienced significant increases (t= 8.35;
P< 0.001) in RBCs from 4.24 ± 0.379 to 4.49 ± 0.42 million
cells/lL, with a 5.89% change. However Group B experienced
significant declines (t= 10.38; P< 0.001) in RBCs from 4.30
± 0.317 to 3.74 ± 0.33 million cells/lL with a 13.02%
change. Results are illustrated in Fig. 2.
Post-treatment hemoglobin and red blood cell count in the two
groups (A and B)
Table 4 shows that, after 12-week of moderate-intensity aero-
bic exercise, there was a significant statistical difference
between the two groups post-treatment in the measured vari-ables, Hb and RBCs; where t-values were [(5.34) and
(5.314)] and P-values were [(0.001) and (0.001), respectively].
Discussion
The present study investigated the impact of moderate-
intensity aerobic exercise on chemotherapy-induced anemia
in breast cancer patients undergoing chemotherapy. Women
undergoing chemotherapy for breast cancer ordinarily encoun-
ter declines in erythrocyte levels that may last several months
after treatment [18]. Declines in erythrocyte levels may be asso-
ciated with chemotherapy complications that incorporate fati-
gue, anemia, depression, and diminished physical capacity
[19,20]. Lessened erythrocyte levels have also been associated
with increased local and regional failure and diminished sur-
vival rates in some cancers [21,22].
Error bars denotes standard deviation
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Fig. 2 Red blood cell count (RBCs) in the two groups pre and
post-treatment.
Table 3 Red blood cell count (RBCs) in the two groups pre and post-treatment.
Variable Groups
RBCs (106/lL)
Group (A) (N= 15) Group (B) (N= 15)
Pre-treatment Post-treatment Pre-treatment Post-treatment
Mean ± SD 4.24 ± 0.37 4.49 ± 0.42 4.30 ± 0.31 3.74 ± 0.33
Percentage of Change 5.89% 13.02%
t-value 8.35 10.38
P-value 0.001* 0.001*
SD= Standard Deviation. Level of significance at P 6 0.05.
* P 6 0.05.
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erate intensity aerobic exercise during chemotherapy of breast
cancer could keep the declines in erythrocyte levels that were
experienced by their non-training peers, where there were sta-
tistically significant differences in the two groups with note-
worthy decline of both Hb and RBCs in group B relative to
group A.
Few studies have assessed the impact of exercise on Hb in
breast cancer patients undergoing chemotherapy. Dimeo
et al. [11] examined the effects of 6 weeks of treadmill walking
after the completion of high-dose chemotherapy and autolo-
gous peripheral stem cell transplantation. After training, walk-
ing speed and hemoglobin increased significantly in the
training subjects, whereas non-training subjects’ values
remained statistically unchanged.
They have proposed that aerobic exercise can induce cor-
rection of anemia in cancer patients after myelotoxic
chemotherapy, decrease fatigue, and enhance emotional and
mood state in these patients and thus physical rehabilitation
is strongly recommended.Table 4 Post-treatment hemoglobin (Hb) and red blood cell count
Variable Hb (g/dL)
Group (A) (N= 15) Group (B) (N=
Mean ± SD 12.10 ± 0.59 10.32 ± 1.04
t-value 5.722
P-value 0.001*
SD= Standard Deviation Level of significance at P 6 0.05.
* P 6 0.05.Drouin et al. [12] assessed the effects of 7 weeks of aerobic
exercise training on erythrocyte levels during radiation therapy
for breast cancer. After training, erythrocyte levels increased
significantly in the training subjects in contrast to the non-
training ones.
Lianne et al. [23] stated that enhancement of oxygen trans-
port and tissue oxidative capacity after Low- to moderate-
intensity aerobic exercise caused by increased blood volume
through an increase in plasma volume and (RBCs) mass,
improved red cell deformability and decreased blood viscosity
that may have allowed patients to maintain their aerobic
capacity during chemotherapy.
Walking is a weight-bearing activity that has its effect on
bone and bone marrow. Bone is able to detect and adapt to
mechanical stimulation by modulating its mass, geometry and
structure as it is a dynamic tissue. These changes might be
because of the mechanical stimulation applied on the bone tis-
sues in the form of walking. This mechanical stimulation had
an impact on the process of blood formation occurring mainly
in the bone marrow. From this, one can see that there is a close
relation between bone tissues and hematopoietic processes
[24,25].
Dimeo et al. [26] have found that endurance exercises ’in
the form of walking on a treadmill’ at an intensity of 80%
of the maximal heart rate enhances the process of hematopoi-
esis as a result of increased production of growth hormone in
anemic patients. They have found that intense or prolonged
exercise has been shown to affect the concentration of several
cytokines and hormones that regulate the self-renewal, prolif-
eration and maturation of blood stem cells.
However, few studies on this topic did not find significant
differences in erythrocyte levels between training and non-
training subjects. Schwartz et al. [27] examined the treatment
with endurance training during either conventional or high-
dose chemotherapy with stem cell rescue. Although partici-
pants walked daily on a treadmill for 30 days, physical perfor-
mance and erythrocyte measures stayed unchanged proposing(RBCs) in the two groups (A and B).
RBCs (106/lL)
15) Group (A) (N= 15) Group (B) (N= 15)
4.49 ± 0.42 3.74 ± 0.33
5.314
0.001*
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adequate for training effect to occur.
Also, Fetscher et al. [28] examined the effect of aerobic
exercise in cancer patients during high-dose chemotherapy.
Training intensity was 50% of the maximum heart rate and
training duration was 13–15 days. They did not find significant
differences in erythrocyte levels between trained and untrained
subjects. This may also be attributed to inefficient training
intensity or duration to cause changes in erythrocyte measures.
The limitation of the current study is that changes in ery-
throcyte levels were not assessed aerobically, so it would be
beneficial that subsequent studies determine its association
with changes in aerobic capacity (VO2peak).
Conclusions
Moderate intensity aerobic exercise has valuable effects on
chemotherapy-induced anemia in elderly women with breast
cancer as evidenced by the significant increase in mean values
of Hb and RBCs in the study group compared with the control
group. In turn, these results could provide healthcare profes-
sionals with an appropriate non-pharmacologic intervention
to counteract the decline in erythrocyte observed in many
breast cancer patients undergoing chemotherapy.
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